RT Journal Article
SR Electronic
T1 COVID-19 Reproduction Numbers and Long COVID Prevalences in California State Prisons
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.12.14.24319022
DO 10.1101/2024.12.14.24319022
A1 Worden, Lee
A1 Wannier, Rae
A1 Archer, Helena
A1 Blumberg, Seth
A1 Kwan, Ada
A1 Sears, David
A1 Porco, Travis C.
YR 2024
UL http://medrxiv.org/content/early/2024/12/16/2024.12.14.24319022.abstract
AB Prisons have been hotspots for COVID-19 and likely an important driver of racial disparity in disease burden. From the first COVID-19 case detected through March 25, 2022, 66,684 of 196,652 residents of California’s state prison system were infected, most of them in two large winter waves of outbreaks that reached all 35 of the state prisons. We used individual-level data on disease timing and nightly room assignments in these prisons to reconstruct locations and pathways of transmission statistically, and from that estimated reproduction numbers, locations of unobserved infection events, and the subsequent magnitude and distribution of long COVID prevalence. Where earlier work has recommended smaller cells over large dormitory housing to reduce transmission, recommended use of cells with solid doors over those with bars only, and cautioned against reliance on solid doors (e.g., in cold months when HVAC systems can circulate aerosols), we found evidence of substantial transmission in both dorms and cells regardless of the door and season. Effective reproduction numbers were found to range largely between 0 and 5, in both cells and dorms of all door types. Our estimates of excess case rates suggest that as a result of disparities in incarceration, prison outbreaks contributed to disproportionate disease burden on Black and Indigenous people in California. We estimated that 9,100–11,000 people have developed long COVID as a result of infection in these prison outbreaks, 1,700–2,000 of them with disabling consequences, and that this burden is disproportionately on Black and Indigenous people in comparison to the state as a whole. We urge high-quality medical care for prison residents affected by long COVID, and decarceration to reduce the risk of future outbreaks of both COVID-19 and other diseases.Competing Interest StatementLW, HA, AK, and DS received funding from the California Prison Receivership Office.Funding StatementLW and TCP were supported by NIH GM130900. SB and TCP were supported by CDC U01CK000590, as part of the Modeling Infectious Diseases in Healthcare Network. SB was also supported by NIH K12 EY031372. LW, HA, AK, and DS received funding from the California Prison Receivership Office. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of the University of California, San Francisco gave ethical approval for this work. The IRB (IRB no. 21-34030) waived the need for informed consent given the use of secondary deidentified datasets based on the following criteria: deemed no more than minimal risk to subjects; could not practicably be done without the waiver; will not adversely affect rights and welfare of subjects; and will provide subjects with additional pertinent information after participation. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesOur data sharing agreement with CDCR and CCHCS does not permit publication of the raw source data. Data requests may be made to the California Correctional Health Care Services and are subject to controlled access, due to requirements to enhance protection of this vulnerable incarcerated population. Source code used in the analysis is available on request from the corresponding author.